rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-2-25
|
pubmed:abstractText |
To assess whether the sum of ST segment elevation and depression (ST segment deviation score [SUMSTdev]) is a better predictor for 24 h, nonfatal complications in patients with acute myocardial infarction (MI) than the sum of ST segment elevation (SUMSTelev) alone in the admission electrocardiogram.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0828-282X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-7
|
pubmed:dateRevised |
2008-4-9
|
pubmed:meshHeading |
pubmed-meshheading:12601440-Adult,
pubmed-meshheading:12601440-Aged,
pubmed-meshheading:12601440-Arrhythmias, Cardiac,
pubmed-meshheading:12601440-Aspirin,
pubmed-meshheading:12601440-Electrocardiography,
pubmed-meshheading:12601440-Fibrinolytic Agents,
pubmed-meshheading:12601440-Heart Failure,
pubmed-meshheading:12601440-Heparin,
pubmed-meshheading:12601440-Hospital Mortality,
pubmed-meshheading:12601440-Humans,
pubmed-meshheading:12601440-Male,
pubmed-meshheading:12601440-Middle Aged,
pubmed-meshheading:12601440-Myocardial Infarction,
pubmed-meshheading:12601440-Predictive Value of Tests,
pubmed-meshheading:12601440-Prospective Studies,
pubmed-meshheading:12601440-Risk Factors,
pubmed-meshheading:12601440-Thrombolytic Therapy,
pubmed-meshheading:12601440-Tissue Plasminogen Activator
|
pubmed:year |
2003
|
pubmed:articleTitle |
Prediction of 24 h, nonfatal complications in patients with acute myocardial infarction receiving thrombolytic therapy by calculation of the ST segment deviation score.
|
pubmed:affiliation |
University Clinic of Emergency Medicine, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|